Stay updated on Seladelpar in PBC Subjects Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.

Latest updates to the Seladelpar in PBC Subjects Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 of the site software.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1. The change is a backend/site update and does not modify study information displayed to users.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. No changes to study content or visible functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedThe label 'Last Update Posted' is now shown, replacing the previous 'Last Update Posted (Estimated)' label. This clarifies that the last update is a posted date rather than an estimated one.SummaryDifference0.0%

- Check61 days agoChange DetectedMinor version update from v3.3.3 to v3.3.4; no changes to study content, eligibility criteria, or visible page information were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded the full ASSURE study details for Seladelpar in Primary Biliary Cholangitis (PBC), including expanded US and international locations, updated inclusion/exclusion criteria, design, and outcome measures. The page now reflects current protocol information and replaces older content.SummaryDifference2%

Stay in the know with updates to Seladelpar in PBC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.